The Quadram Institute is an interdisciplinary research centre capitalising on the academic excellence and clinical expertise of the Norwich Research Park. Its mission is to understand how food and the gut microbiota link to the promotion of health and the prevention of diet and age-related diseases. It brings together fundamental and translational science with a clinical research facility for human trials and one of Europe’s largest gastrointestinal endoscopy units. The Quadram Institute is accelerating innovation by synergising interactions between basic and clinical research, delivering a step-change in the understanding of the role of food and the microbiome on health.
By understanding biology and empowering action, Quantum-Si aims to improve human health. We provide researchers, scientists and clinicians with a convenient solution that reveals in-depth, proteomic insight in an easy-to-use accessible workflow. Our technology allows them to expand their understanding of cell biology and disease by uncovering what is there and not what could be there, which opens the door to the development of new diagnostics and discovery of novel, lifesaving drugs.
QMB is the largest purpose-built space in London for companies in science and technology, and the only centre to offer follow-on growth space for companies emerging from incubator space.. . Accommodation is available in flexible suite sizes from 500 square feet with flexible competitively-priced leases to other London based offerings. The flexibility of the centre means space can be easily reconfigured in response to meet a tenant's needs.
Queen May Innovation Ltd (QMI), is the wholly owned technology transfer subsidiary of Queen Mary, University of London. QMI is responsible for identifying, protecting and commercialising novel technologies in medicine and dentistry, healthcare, science and engineering. QMI manages a large and varied portfolio of licensed technologies and spin-out companies. With around 16,900 students, 3800 staff and an annual turnover of £300m, we are one of the biggest University of London colleges. The London School of Medicine and Dentistry faculty focuses on: translational research, cancer, cardiac, dentistry, inflammation, endocrinology/metabolism, immunology and infectious diseases, genomics, neuroscience, gastroenterology, epidemiology and primary care.
The Business Development Office provides access to Queen Mary University of London cutting-edge capabilities and state-of–the-art facilities. Our team of Business Development Managers will identify relevant academic expertise to meet your commercial requirements through collaborative research, contract research and consultancy.
Quotient Sciences are dedicated to accelerating the development of new drugs for patients around the world. They provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via their Translational Pharmaceutics® platform.. . For more than 30 years, Quotient Sciences has brought innovation to early drug development programs for pharmaceutical companies worldwide. At the company’s purpose built facilities, real-time manufacturing of all types of dosage forms is co-located with its clinical pharmacology unit to maximise flexibility, speed and cost savings for clients.
No data available
Established about 10 years ago to discover new anti-infection molecules to replace antibiotics and avoid resistance. We succeeded in creating a platform technology that offers several small molecules offering elimination of a range of pathogens to fight bacteria. viruses and fungal pathogens. It also offers performance in anti-aging, mental problems and solving many problems relating to the Gut Microbiome yet doing no damage to commensal bacteria or human cells. Our patent has been granted by EUIPO. Delivery systems have also been developed to work on other organs.
Reading Scientific Services Limited (RSSL) provides analytical, investigational, consultancy and training services to clients in the global biopharmaceutical, pharmaceutical and healthcare industries. We help our partners to develop drug products that are safe, innovative and of the highest quality.
Our GMP compliant facilities are located in the UK and with our team of more than 200 dedicated scientists, we ensure that every project is performed with our absolute commitment to outstanding quality, scientific excellence and customer satisfaction.
We offer a large portfolio of biological, microbiological, chemical and physical services to ensure the identity, purity, safety and quality of your biopharmaceutical through the full drug product life cycle.
Our comprehensive range of services include:
• Raw materials testing
• Biopharmaceutical characterisation
• Safety testing
• ICH stability testing
• Release testing
• Troubleshooting and contaminant identification
• 24/7 Emergency response service
• Training and consultancy
Our GMP compliant facilities are located in the UK and with our team of more than 200 dedicated scientists, we ensure that every project is performed with our absolute commitment to outstanding quality, scientific excellence and customer satisfaction.
We offer a large portfolio of biological, microbiological, chemical and physical services to ensure the identity, purity, safety and quality of your biopharmaceutical through the full drug product life cycle.
Our comprehensive range of services include:
• Raw materials testing
• Biopharmaceutical characterisation
• Safety testing
• ICH stability testing
• Release testing
• Troubleshooting and contaminant identification
• 24/7 Emergency response service
• Training and consultancy
With a client base representing companies from the FT Global 500 and FTSE listed companies, Reddie & Grose is recognised as a leading patent and trade mark firm. In 2009, the Managing Intellectual Property global patent survey ranked the firm as one of the UK’s top patent prosecution advisors. It consistently continues to achieve high rankings in all professional surveys.. . Reddie & Grose prides itself on delivering intellectual property protection for businesses in both the domestic and international marketplaces with a strong professional team of over 30 people from varied scientific backgrounds.. . The firm’s Cambridge office offers particular expertise in biotechnology, pharmaceutical, chemical, engineering, cleantech, instrumentation, medical device, materials, and software related inventions. Companies/academic institutions represented in this field by Reddie & Grose include: Diagnostics for the Real World, Haemostatix, Funxional Therapeutics, TCP Innovations, Trillion Genomics, Brax, Cambridge Biopolymers, Metalysis, University of Cambridge, Cambridge Broadband, i2, Cambridge Biotechnology Ltd and nCipher.. . Talk to us...
Watch our webinar with One Nucleus 'What are the IP Challenges at the Intersection of Life Sciences, Technology and Engineering Disciplines?' https://youtu.be/OHM3IoLoJ0Q
Watch our webinar with One Nucleus 'What are the IP Challenges at the Intersection of Life Sciences, Technology and Engineering Disciplines?' https://youtu.be/OHM3IoLoJ0Q